With recent increases in annual gonorrhoea incidence and disproportionately high infection rates amongst men who have sex with men, the clinical picture of disseminated gonococcal infection is changing. We present two cases where consideration of, and investigation for, disseminated Neisseria gonorrhoeae infection provided the answer when routine inpatient diagnostics had been unsuccessful.
BelkacemACaumesEOuanichJ. Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011. Sex Transm Infect2013; 89: 613–615.
TaylorSNLiesenfeldOLillisRA. Evaluation of the Roche Cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis2012; 39: 543–549.
12.
United Kingdom National Guideline for Gonorrhoea Testing. Clinical effectiveness group, British association of sexual health and HIV, www.bashh.org/guidelines (2012, accessed 16 April 2015).
13.
Public Health England. Guidance for the detection of gonorrhoea in England, www.bashh.org/guidelines (2014, accessed 16 April 2015).
14.
KinghornG. Pharyngeal gonorrhoea: a silent cause for concern. Sex Transm Infect2010; 86: 413–414.
15.
Obi C, Hughes G, Ison CA, et al. Risk factors, antimicrobial susceptibility profiles and public health implications of patients presenting with pharyngeal gonococcal infection in England and Wales. In: Stary A (ed.) STI & AIDS world congress 2013, Vienna, Austria, 14–17 July 2013, paper no. P3.120. Sex Transm Infect 2013; 89(Suppl 1): A185.
16.
ChenMYStevensKTidemanR. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother2013; 68: 1445–1447.